BRKR | Ticker Profile - Titan Protect

BRKR

Bruker Corporation

Healthcare · Medical Devices · NMS

$56.39

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$7.4B

Total market value of the company

Trailing P/E

N/A

Forward P/E

20.11

Based on estimated future earnings — lower means cheaper

Rev Growth

+2.7%

Year-over-year revenue change

Profit Margin

-0.3%

How much profit the company keeps from each dollar of revenue

ROE

-0.4%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$50.00

-11% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 13 analysts covering this stock

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

https://www.bruker.com

Country: United States Employees: 11,085 Industry: Medical Devices

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

-0.037

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0067

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.221

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-13.1%

Historical annualised return based on price data

Max Drawdown

-59.4%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.12

Moves slightly more than the broader market

52W High

$56.22

-0% below the year high

52W Low

$28.53

98% above the year low

Avg Volume

2,131,670

Average daily shares traded — higher means easier to buy and sell

Short Ratio

5.6

Days it would take all short sellers to cover — higher means more crowded

Short % Float

17.0%

Elevated short interest — bears are positioned against this

Div Yield

41.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.24

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

68.12

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.55

Healthy liquidity position

Quick Ratio

0.65

Like current ratio but excludes inventory — stricter test

Gross Margin

47.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

6.2%

Profit from core operations before interest and tax

Free Cash Flow

$212M

Positive — the business generates more cash than it spends

Revenue (TTM)

$3.5B

Total revenue over the last 12 months

Net Income

$-36,400,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$60.00

Target Median

$50.00

Target Low

$35.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go